Keywords: Sttallergenes. Shionogi, License, Japan, Taiwan, Actair, Stalair, Allergens
France’s Stallergenes licenses two allergens to Japan’s Shionogi for up to 70 million euros
Article | 08 September 2010
French group Stallergenes (GENP: FP) has signed an exclusive partnership agreements with Japanese drug major Shionogi (TKO; 4507) for two sublingual ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
